Company / SG&A per Share
MARAVAI LIFESCIENCES HOLDINGS, INC. SG&A per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.10
FY2025
5-year range
$0.39 / $4.47
FY2021-FY2025
Trend
+73.6%
vs FY2024
Sector context
#115 of 210
Health Care
What the data says
At $1.10, MARAVAI LIFESCIENCES HOLDINGS, INC.'s sg&a per share ranks #96 of 210 in the Health Care sector. SG&A per Share has fluctuated over the past 7 years, ranging from $0.19 in FY2019 to $4.47 in FY2022.
Based on SEC 10-K filings.
1.10 in FY2025 with a 5-year CAGR of -19.5%.
Increased from $0.59 to $1.10 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -37.3%
- 5-Year CAGR
- -19.5%
- 10-Year CAGR
- -
Sector benchmark
#96 of 210 in Health CareTop 45% of 210This company $1.10 Sector average $40.75
▼
-97.3% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 73.6% year-over-year.
- Ranks #115 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2022.
- Lowest sg&a per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.10 | +73.6% |
| FY2024 | $0.63 | +7.9% |
| FY2023 | $0.59 | -86.9% |
| FY2022 | $4.47 | +1034.6% |
| FY2021 | $0.39 | -87.9% |
| FY2020 | $3.26 | +1612.0% |
| FY2019 | $0.19 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026